关键词：基药采购；品规

查看摘要 索取原文[1页]

The Global Parkinson's Disease market is expected to grow at a steady pace during the period 2012-2016. The market was dominated by the Americas in 2012, and was followed by the EMEA and APAC regions. Currently, a major part of the market growth is derived from the Dopamine Agonists segment. Other segments, such as the COMT Inhibitor segment and the Dopamine Replacement Agents segment, are expected to make significant contributions to the revenue of the overall market in the next few years. Factors such as the lack of efficacious products in the market, various patent expirations, and a weak pipeline are expected to limit the growth of the Global Parkinson's Disease market during the forecast period. Currently, the market has limited treatment options and numerous unmet needs in Parkinson's disease treatment. However, new entrants are expected to gain a significant market share during the forecast period as they are developing numerous novel molecules which have the potential to alter the progression of the disease. The Global Parkinson's Disease market is expected to post a CAGR of 1.67 percent during the forecast period.

关键词：帕金森氏症；神经变性疾病；多巴胺

查看摘要 索取原文[53页]

The Global Orthopedic Bracing and Supports market is growing at a steady rate. The Americas dominated the market, followed by the EMEA region and the APAC region. The US, which has the world's highest per capita healthcare expenditure, was the leading country in the Global Orthopedic Bracing and Supports market in 2012. The market is expected to witness an improvement in its growth rate and is estimated to grow at a CAGR of 4.66 percent during the period 2012-2016.

关键词：热塑性塑料；全球骨科支撑；支持市场

查看摘要 索取原文[59页]

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

关键词：医药；政策环境；市场行情；厂商动态；科技研发；国际资讯；行业数据；分析评论

查看摘要 索取原文[74页]

关键词：抗生素；需求；收购；卡毕斯特；Optimer制药；Trius治疗公司

查看摘要 索取原文[1页]

关键词：药品管理法；修改

查看摘要 索取原文[1页]

关键词：生物技术；产业链

查看摘要 索取原文[1页]

关键词：北大医药；抗癌新药 ；专项资金

查看摘要 索取原文[1页]

关键词：中西医结合；中医药；海外发展

查看摘要 索取原文[1页]

上半年，在世界经济缓慢复苏，全球医药市场格局变化和我国医药内需发展强劲等内外因素的共同作用下，我国生物药品制造业出口交货值自2013年初扭转上年持续下滑态势之后，始终保持较快增长态势。上半年，我国生物药品制造业出口交货值为104.22亿元，同比增长11.56%，而上年同期为下降4.79%。3季度，宏观经济有望稳中略有回升，国内消费市场总体需求有望好转。预计2013年全年，生物药品制造业将保持良好发展势头，疫苗批签发量将保持快速增长；国外医药景气度将有所回温，生物药品制造业出口交货值将达到207亿元， 同比增长11.7%左右；全年实现销售收入约2412亿元，同比增长17.8%左右；实现利润总额约311亿元，同比增长约22%。

关键词：生物制药；当季概览；供求分析；趋势预测；政策解读

查看摘要 索取原文[33页]